Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML …
G Marzocchi, F Castagnetti, S Luatti… - Blood, The Journal …, 2011 - ashpublications.org
Abstract Variant Philadelphia (Ph) chromosome translocations have been reported in 5%-
10% of patients with newly diagnosed chronic myeloid leukemia (CML). Variant …
10% of patients with newly diagnosed chronic myeloid leukemia (CML). Variant …
[引用][C] Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on …
G Marzocchi, F Castagnetti, S Luatti, C Baldazzi… - BLOOD, 2011 - ricerca.uniba.it
[HTML][HTML] Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party …
G Marzocchi, F Castagnetti, S Luatti, C Baldazzi… - Blood, 2011 - Elsevier
Abstract Variant Philadelphia (Ph) chromosome translocations have been reported in 5%-
10% of patients with newly diagnosed chronic myeloid leukemia (CML). Variant …
10% of patients with newly diagnosed chronic myeloid leukemia (CML). Variant …
Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML …
G Marzocchi, F Castagnetti, S Luatti, C Baldazzi… - Blood, 2011 - europepmc.org
Variant Philadelphia (Ph) chromosome translocations have been reported in 5%-10% of
patients with newly diagnosed chronic myeloid leukemia (CML). Variant translocations may …
patients with newly diagnosed chronic myeloid leukemia (CML). Variant translocations may …
Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML …
G Marzocchi, F Castagnetti, S Luatti, C Baldazzi… - Blood, 2011 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Variant Philadelphia (Ph) chromosome
translocations have been reported in 5%-10% of patients with newly diagnosed chronic …
translocations have been reported in 5%-10% of patients with newly diagnosed chronic …
Variant Philadelphia translocations: Molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA working party on CML …
G Marzocchi, F Castagnetti, S Luatti, C Baldazzi… - BLOOD, 2011 - usiena-air.unisi.it
Abstract Variant Philadelphia (Ph) chromosome translocations have been reported in 5%-
10% of patients with newly diagnosed chronic myeloid leukemia (CML). Variant …
10% of patients with newly diagnosed chronic myeloid leukemia (CML). Variant …
[引用][C] Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA WP on CML …
G Marzocchi, F Castagnetti, S Luatti, C Baldazzi… - BLOOD, 2011 - iris.unito.it
Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML …
G Marzocchi, F Castagnetti, S Luatti, C Baldazzi… - BLOOD, 2011 - iris.unina.it
Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic
influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis. IRIS IRIS …
influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis. IRIS IRIS …
[引用][C] Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on …
G MARZOCCHI, F CASTAGNETTI, L VALORI… - Blood, 2011 - pascal-francis.inist.fr
Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic
influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis CNRS Inist …
influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis CNRS Inist …
Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML …
G Marzocchi, F Castagnetti, S Luatti, C Baldazzi… - …, 2011 - pubmed.ncbi.nlm.nih.gov
Variant Philadelphia (Ph) chromosome translocations have been reported in 5%-10% of
patients with newly diagnosed chronic myeloid leukemia (CML). Variant translocations may …
patients with newly diagnosed chronic myeloid leukemia (CML). Variant translocations may …